ITRM - Iterum Therapeutics PLC - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

ITRM is currently covered by 1 analysts with an average price target of $6.48. This is a potential upside of $5.03 (346.9%) from yesterday's end of day stock price of $1.45.

Iterum Therapeutics PLC's activity chart (see below) currently has 9 price targets and 12 ratings on display. The stock rating distribution of ITRM is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 40% with an average time for these price targets to be met of 165 days.

Highest price target for ITRM is $6, Lowest price target is $6, average price target is $6.48.

Most recent stock forecast was given by ED ARCE from HC WAINWRIGHT on 01-Apr-2024. First documented stock forecast 19-Jun-2018.

Best performing analysts who are covering ITRM - Iterum Therapeutics PLC:

Gregory Renza Ed Arce

Currently out of the existing stock ratings of ITRM, 2 are a BUY (100%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

6

$4.3 (252.94%)

6

18 days ago

0/3 (0%)

$4.36 (265.85%)

Buy

30

$28.3 (1664.71%)

8

3 years 10 months 17 days ago

4/5 (80%)

$5.7 (23.46%)

330

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ITRM (Iterum Therapeutics PLC) average time for price targets to be met?

On average it took 165 days on average for the stock forecasts to be realized with a an average price target met ratio 40

Which analyst has the current highest performing score on ITRM (Iterum Therapeutics PLC) with a proven track record?

GREGORY RENZA

Which analyst has the current lower performing score on ITRM (Iterum Therapeutics PLC) with a proven track record?

ED ARCE

Which analyst has the most public recommendations on ITRM (Iterum Therapeutics PLC)?

Gregory Renza works at RBC and has 11 price targets and 9 ratings on ITRM

Which analyst is the currently most bullish on ITRM (Iterum Therapeutics PLC)?

Gregory Renza with highest potential upside - $28.3

Which analyst is the currently most reserved on ITRM (Iterum Therapeutics PLC)?

Ed Arce with lowest potential downside - $4.3

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?